Copper · METAL
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-13Copper shows approved-linked disease relevance led by Wilson disease. 5 more disease programs remain visible in the same review block. 5 linked drugs keep the current disease frame grounded. Use Wilson disease as the disease frame, then confirm a stable protein accession before cross-source reuse.
Use Wilson disease as the disease frame, then confirm a stable protein accession before cross-source reuse.
Copper shows approved-linked disease relevance led by Wilson disease. 5 more disease programs remain visible in the same review block. 5 linked drugs remain visible in the same block.
Start review with Wilson disease because it currently carries approved-linked support. Linked drugs include PENICILLAMINE, TIOMOLIBDATE CHOLINE, TIOMOLIBDATE ION, TRIENTINE HYDROCHLORIDE. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
Disease source · ChEMBL drug mechanism + indication proxyCopper
Review this target as Copper.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Copper as ChEMBL target CHEMBL2363057. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Copper still has a stable protein naming contract across sources.
Jump to Protein ContextUse this block first when you need to confirm why Wilson disease is currently framed as approved-linked support. It currently carries 5 linked drugs in the same disease frame.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Copper |
| Target Type | METAL |
| Organism | None |
Reviewable protein naming and mapping context for this target snapshot.
Review this target as Copper.
Open Targets-ready disease context using the current target-indication evidence contract.
Copper shows approved-linked disease relevance led by Wilson disease. 5 more disease programs remain visible in the same review block.
Start review with Wilson disease because it currently carries approved-linked support. Linked drugs include PENICILLAMINE, TIOMOLIBDATE CHOLINE, TIOMOLIBDATE ION, TRIENTINE HYDROCHLORIDE. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.